Navigation Links
Keiretsu Forum Mid-Atlantic Launches July Four-City Road Show
Date:7/19/2013

New York, NY (PRWEB) July 19, 2013

The Keiretsu Forum Mid-Atlantic Region (K4-MA) – with chapters in Philadelphia, DC, Pittsburgh, and New York – a part of the global Keiretsu Forum angel network, announced that it will present five early stage companies to investors at next week’s monthly forum event. Three of the companies are life science companies. Attendance is by invitation only.

More than 100 accredited investors will see the same companies present their business investment opportunities Tuesday morning, July 23 in New York, Wednesday in Philadelphia, Thursday in Washington, DC, and Friday in Pittsburgh. The presenting companies will be:

  • Carmell Therapeutics develops biomaterials manufactured from blood plasma that are used in products that naturally promote and accelerate the healing of injuries to bone and soft tissues.
  • Codex Therapeutics develops a topical gel that is shown to substantially reverse chronic wound healing times for diabetic, pressure and venous.
  • Imagistix Inc. is a frequency and high resolution ultrasound imaging system poised to revolutionize the detection and treatment of prostate cancer in men.
  • Yorn® (Your Opinion Right Now) is an innovative real-time engagement platform with compelling evidence that it helps organizations understand and improve the customer/patient experience.
  • Guardian8 is a manufacturer of personal protection security devices that offer non-lethal solutions for layered defense and incident recording.

Two of the K4-MA cities are among the five top metropolitan regions for life sciences venture funding. According to recent data from PricewaterhouseCoopers LLP, venture capitalists invested $1.4 billion in 167 Life Sciences deals during the first quarter of 2013. New York was one of three of the five regions that saw double-digit increases in investing in Q1 2013, incre
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. The Galien Foundation Celebrates Biomedical Innovation in Fourth Galien Forum
2. Synthetic Biologics to Present at OneMedForum New York 2013
3. NSBRI Industry Forum Launches SMARTCAP-Accel, a Grant Funding Opportunity to Catalyze Development of Products for Spaceflight
4. MedTech Innovate Seminars: New Interactive Learning Forums at 2013 MD&M East
5. ClearPath Workforce Management CEO Appointed Co-chair of Northern California Leadership Forum for Woman Owned Business Alliance
6. Ultra Light Startups Hosts Future Energy Investor Feedback Forum at MIT
7. Bayer CropScience Names Jeremy Jack 2013 Young Sustainable Farmer at Ag Issues Forum
8. Bayer CropScience Hosts 8th Annual Ag Issues Forum
9. BCA Represents Independent Blood Centers at Phacilitate Cell & Gene Therapy Forum
10. The Conference Forum Announces A New Medicaid Rebate Summit for Early 2013
11. Bayer CropScience Hosts Inaugural Vegetable Future Forum in Monheim
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... ST. LOUIS, July 30, 2015 ... period in 2014) , Reported sales were $697 ... of 2014.  Sales grew organically by 8%, and changes ... Recent acquisitions increased sales by 1%. , By ... 8% in Applied and 11% in SAFC Commercial. ...
(Date:7/30/2015)... , ... July 30, 2015 , ... As part of its 2015 growth plan and ... and technical service business units, Whitehouse Laboratories is pleased to announce that it ... to the Container Center of Excellence and will be strictly dedicated to basic USP 51, ...
(Date:7/29/2015)... July 30, 2015 Sanofi, ... for the second quarter of 2015. CEO ... and its performance in different businesses. ... http://www.eurobusinessmedia.com/ceo-direct/sanofi/sanofi-h1-2015-results-interview-with-ceo-olivier-brandicourt?utm_source=ceo-direct&utm_medium=wire Topics covered in ... - Performance drivers - ...
(Date:7/29/2015)... July 30, 2015 According to a ... Growth, Trends & Forecasts (2015-2020), , published by Mordor Intelligence, ... billion by the end of 2020, with North ... more than 40% of the global market size. The Global ... CAGR of 13.7% during the period of (2015-2020). ...
Breaking Biology Technology:Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 2Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 3Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 4Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 5Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 6Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 7Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 8Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 9Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 10Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 11Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 12Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 13Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 14Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 15Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 16Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 17Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 18Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 19Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 20Whitehouse Labs Formally Announces Plans to Open a Microbiological Laboratory 2Asia Pacific to Dominate the Global Stem Cell Market - Vericel Corporation, Ocata Therpeutics, Athersys Inc., Cryo-Cell International, Geron Corporation, StemCells, Inc. Among the Major Players 2Asia Pacific to Dominate the Global Stem Cell Market - Vericel Corporation, Ocata Therpeutics, Athersys Inc., Cryo-Cell International, Geron Corporation, StemCells, Inc. Among the Major Players 3
... , PALO ALTO, Calif., Sept. 21 Varian, ... to enhance the flexibility and automated use of its 400-MR ... comprises the OneNMR(TM) probe, a choice of two autosamplers, and ... sample throughput and streamlined data management in mind, each piece ...
... LONDON and SAN CARLOS, Calif., Sept. 21 ... into an exclusive worldwide license agreement for two drug development ... the treatment of opioid-induced constipation, and the NKTR-119 programme, an ... the treatment of pain without constipation side effects. Both ...
... a lattice of carbon just a single atom deep ... sensors so keen they detect the arrival or departure ... in fuel cells or as energy‐saving transistors and wires. ... abundant material, have so much potential because their function ...
Cached Biology Technology:New Productivity Suite From Varian, Inc. Increases Throughput for NMR Laboratories 2New Productivity Suite From Varian, Inc. Increases Throughput for NMR Laboratories 3AstraZeneca and Nektar Sign Worldwide Agreement for Nektar Drug Development Programmes -- NKTR-118 and NKTR-119 -- to Address Opioid-Induced Constipation 2AstraZeneca and Nektar Sign Worldwide Agreement for Nektar Drug Development Programmes -- NKTR-118 and NKTR-119 -- to Address Opioid-Induced Constipation 3AstraZeneca and Nektar Sign Worldwide Agreement for Nektar Drug Development Programmes -- NKTR-118 and NKTR-119 -- to Address Opioid-Induced Constipation 4AstraZeneca and Nektar Sign Worldwide Agreement for Nektar Drug Development Programmes -- NKTR-118 and NKTR-119 -- to Address Opioid-Induced Constipation 5A recipe for controlling carbon nanotubes 2
(Date:7/31/2015)... , 31 de julio de 2015 La ... ) se celebrará por medio de BGI del 22 al 25 ... . Este año, la conferencia celebra su ... se ha convertido en una de las reuniones anuales más ... una de las reuniones más dinámicas, entusiastas y mejores a ...
(Date:7/31/2015)... Jul. 31, 2015 NXT-ID, Inc. (NASDAQ: NXTD ... focused on the growing mobile commerce market and creator ... filed provisional patent 62/198989 for ELECTRONIC CRYPTO-CURRENCY ... a method to advance crypto-currencies such as Bitcoin into ... common, uniform way to manage all payments.  ...
(Date:7/30/2015)... 2015 Cellecta, Inc., a U.S.-based provider ... and biomarker discovery, announced the release of its ... all human protein coding genes. CRISPR technology enables ... gene,s function. Cellecta,s new Human Whole Genome CRISPR ... so that researchers can investigate in a single ...
Breaking Biology News(10 mins):La 10th International Conference on Genomics (ICG-10) se llevará a cabo en octubre 2La 10th International Conference on Genomics (ICG-10) se llevará a cabo en octubre 3NXT-ID Patents Electronic Crypto-Currency Management Technology 2NXT-ID Patents Electronic Crypto-Currency Management Technology 3NXT-ID Patents Electronic Crypto-Currency Management Technology 4CELLECTA, INC. Announces Launch of Human Whole Genome CRISPR Knockout Library 2
... heart becomes diseased during its embryonic/fetal development, it can ... fully functional by birth, provided some of the heart ... Delbrck Center for Molecular Medicine (MDC) Berlin-Buch made this ... to demonstrate in female mice that the healthy cells ...
... in Cancer Research , a journal of the American ... in breast tumor development and metastases. The study, ... is among the first to explore the effects of nicotine ... role of nicotine exposure in tumor promotion, little is known ...
... broadleaf weeds in corn, but also annihilated most of ... finally have a worthy contender. Researchers at the University ... Chancellor which is resistant to the popular herbicide 2, ... introduced. It was a wonder herbicide," said Robert Skirvin, ...
Cached Biology News:Repair in the developing heart 2Study links nicotine with breast cancer growth and spread 2Herbicide-resistant grape could revitalize Midwest wine industry 2Herbicide-resistant grape could revitalize Midwest wine industry 3